BRINTELLIX 20 MG Israele - inglese - Ministry of Health

brintellix 20 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 20 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

BRINTELLIX 5 MG Israele - inglese - Ministry of Health

brintellix 5 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

BRINTELLIX 5 MG Israele - inglese - Ministry of Health

brintellix 5 mg

lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.

Mirataz Unione Europea - inglese - EMA (European Medicines Agency)

mirataz

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - cats - for bodyweight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions.

SPRAVATO SOLUTION Canada - inglese - Health Canada

spravato solution

janssen inc - esketamine (esketamine hydrochloride) - solution - 28mg - esketamine (esketamine hydrochloride) 28mg - miscellaneous antidepressants

SPRAVATO Israele - inglese - Ministry of Health

spravato

j-c health care ltd - esketamine as hydrochloride - solution for spray - esketamine as hydrochloride 28 mg/vial - esketamine - spravato, in combination with a ssri or snri, is indicated for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.spravato, co-administered with oral antidepressant therapy, is indicated in adults with a moderate to severe episode of major depressive disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency.limitations of use: the effectiveness of spravato in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. use of spravato does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of spravato.

SPRAVATO NASAL SPRAY 28MGVIAL Singapore - inglese - HSA (Health Sciences Authority)

spravato nasal spray 28mgvial

johnson & johnson international (singapore) pte ltd - esketamine hcl 32.2mg eqv. to esketamine - spray - esketamine hcl 32.2mg eqv. to esketamine 28mg/vial

Agomaval 25 mg film-coated tablets Malta - inglese - Medicines Authority

agomaval 25 mg film-coated tablets

krka dd novo mesto novo mesto, Šmarješka cesta 6, 8501 novo mesto, slovenia - agomelatine - film-coated tablet - agomelatine 25 milligram(s) - psychoanaleptics

Agomaval 25 mg film-coated tablets Malta - inglese - Medicines Authority

agomaval 25 mg film-coated tablets

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - film-coated tablet - agomelatine 25 mg - psychoanaleptics

MILN-AVENIR 25 MG Israele - inglese - Ministry of Health

miln-avenir 25 mg

bioavenir ltd, israel - milnacipran as hydrochloride - capsules - milnacipran as hydrochloride 25 mg - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old